Letters
& Comments

Our mission is to unite and align key diabetes stakeholders and the larger diabetes community around key diabetes-related policy and legislative efforts in order to elevate diabetes on the national agenda.

DAA Comments to the National Academies of Sciences, Engineering, and Medicine (NASEM) on Racial and Ethnic Health Inequities (September 2022)

DOWNLOAD PDF

DAA CY 2023 Medicare Physician Fee Schedule Comments (September 2022)

DOWNLOAD PDF

DAA Comments HHS RFI on Primary Care (August 2022)

DOWNLOAD PDF

DAA Comments to White House Conference on Hunger Nutrition and Health (July 2022)

DOWNLOAD PDF

DAA Comments to White House Office of Science and Technology Policy (March 2022)

DOWNLOAD PDF

DAA Letter to Congressional Diabetes Caucus Regarding Legislation (March 2022)

DOWNLOAD PDF

DAA Comments to CMS about CY 2023 Medicare Part D (March 2022)

DOWNLOAD PDF

DAA Comments to USPSTF for Screening for Diabetes and Prediabetes in Children and Adolescents (January 2022)

DOWNLOAD PDF

DAA Letter Admiral Rachel Levine Assistant Secretary for Health HHS (November 2021)

DOWNLOAD PDF

DAA Letter to Strategic Planning Team OASH HHS (November 2021)

DOWNLOAD PDF

DAA Letter to Christopher Holliday (November 2021)

DOWNLOAD PDF

DAA Letter to Chiquita Brooks LaSure CMS Administrator (September 2021)

DOWNLOAD PDF

DAA Letter to Congressional Social Determinants of Health Caucus (September 2021)

DOWNLOAD PDF

DAA Letter to Chiquita Brooks LaSure CMS Administrator Regarding CY 2022 Medicare PFS (September 2021)

DOWNLOAD PDF

DAA Oral Comments to National Clinical Care Commission (August 2021)

DOWNLOAD PDF

DAA Letter to Chiquita Brooks LaSure Congratulating on New Role (August 2021)

DOWNLOAD PDF

DAA Letter to Emmeline Ochiai Designated Federal Officer ODPHP OASH HHS (July 2021)

DOWNLOAD PDF

DAA Letter to Shalanda Young Acting Director OMB RFI on Advancing Health Equity (July 2021)

DOWNLOAD PDF

DAA Letter to the National Clinical Care Commission (May 2021)

DOWNLOAD PDF

DAA Letter in Support of ADCES as an Accrediting Organization for DSMT (May 2021)

DOWNLOAD PDF

DAA Letter in Support of ADA as an Accrediting Organization for DSMT (May 2021)

DOWNLOAD PDF

DAA Letter Regarding HHS RFI on Landscape Analysis to Leverage Novel Technologies for Chronic Disease Management (December 2020)

DOWNLOAD PDF

DAA Letter to House and Senate Leadership about Special Diabetes Program Funding (October 2020)

DOWNLOAD PDF

DAA Letter to DeGette and Upton about 21st Century Cures 2.0 Concept Paper (October 2020)

DOWNLOAD PDF

DAA Comments to CMS about FY 21 Medicare Physician Fee Schedule Proposed Rule (October 2020)

DOWNLOAD PDF

DAA Comments to CDC’s Diabetes Prevention Recognition Program Standards (September 2020)

DOWNLOAD PDF

DAA Comments to USPSTF on Screening for Diabetes in Children and Adolescents (August 2020)

DOWNLOAD PDF

DAA Comments to the Taskforce on Telehealth Policy (July 2020)

DOWNLOAD PDF

DAA Letter to the National Clinical Care Commission (July 2020)

DOWNLOAD PDF

DAA Letter to USPSTF on Healthy Diet and Physical Activity Guidelines (June 2020)

DOWNLOAD PDF

DAA Letter to CMMI about MDPP Fixes Needed (May 2020)

DOWNLOAD PDF

DAA Letter to Seema Verma about COVID-19 and Diabetes (April 2020)

DOWNLOAD PDF

DAA Letter to House Appropriations (February 2020)

DOWNLOAD PDF

DAA Letter to CMS Administrator Seema Verma (February 2020)

DOWNLOAD PDF

DAA Letter to the National Clinical Care Commission (February 2020)

DOWNLOAD PDF

Comments to National Clinical Care Commission (June 2019)

DOWNLOAD PDF

Letter to Congressional Telehealth Caucus on Telehealth Legislation (March 2019)

DOWNLOAD PDF

Letter of Support Expanding Access to DSMT Act March (March 2019)

DOWNLOAD PDF

Letter to House and Senate Appropriators FY2020 CDC Funding (March 2019)

DOWNLOAD PDF

Letter to Senate HELP Committee Rising Health Care Costs (March 2019)

DOWNLOAD PDF

Letter to CMS Administrator Verma on Medicare Diabetes Prevention Program (February 2019)

DOWNLOAD PDF

Comments to Healthy People 2030 on Proposed Diabetes Objectives (January 2019)

DOWNLOAD PDF

Comments to National Clinical Care Commission for Inaugural Meeting (October 2018)

DOWNLOAD PDF

Letter to HHS Secretary Azar and FDA Commissioner Gottlieb on Blood Glucose Monitor Accuracy (October 2018)

DOWNLOAD PDF

Comments to HHSCMS Medicare Physician Fee Schedule Proposed Rule (October 2018)

DOWNLOAD PDF

Comments to USPSTF on Draft Research Plan for Abnormal Blood Glucose and Type 2 Diabetes Mellitus Screening (October 2018)

DOWNLOAD PDF

Comments to USPSTF on Draft Research Plan for Diet and Physical Activity to Prevent Cardiovascular Disease in Adults with Risk Factors: Counseling (July 2018)

DOWNLOAD PDF

Letter to CMS Administrator Verma re therapeutic continuous glucose monitor (CGM) coverage policy (April 2018)

DOWNLOAD PDF

Letter to CMS Director of the Center for Medicare Kouzoukas re Diabetes Self-Management Training barriers (March 2018)

DOWNLOAD PDF

Letter to Appropriators supporting sustained, robust funding of the CDC’s chronic disease and diabetes programs (July 2017)

DOWNLOAD PDF

Letter to HHS Secretary Price and CMS Administrator Verma supporting the Medicare Diabetes Prevention Program (June 2017)

DOWNLOAD PDF

Letter to Diabetes Caucus and Capitol Hill Leadership providing context to DAA Health Reform Principles (June 2017)

DOWNLOAD PDF

Letter to Office of Management and Budget Director Mulvaney on using better diabetes treatment to curb health spending (May 2017)

DOWNLOAD PDF

Letter to Senate Finance Committee Chronic Care Working Group on DSMT (May 2017)

DOWNLOAD PDF

Letter to CMS Administrator Verma on barriers to diabetes self-management training (DSMT) in Medicare (April 2017)

DOWNLOAD PDF

Letter to Department of Health and Human Services Secretary Price on DAA 2017 Priorities (March 2017)

DOWNLOAD PDF

Letter to Appropriators re National Diabetes Prevention Program FY18 funding (March 2017)

DOWNLOAD PDF

Letter of Support for Preventing Diabetes in Medicare Act (September 2016)

DOWNLOAD PDF

Comments to HHS/CMS re Medicare Physician Fee Schedule proposed rule (September 2016)

DOWNLOAD PDF

Letter to HHS, Labor and Treasury re FAQ on new USPSTF Diabetes Screening Guideline (July 2016)

DOWNLOAD PDF

Comments to CMS re MACRA regulation (June 2016)

DOWNLOAD PDF

Comments to ICER on Diabetes Prevention Program Draft Report (May 2016)

DOWNLOAD PDF

Letter to Appropriators re National Diabetes Prevention Program FY17 funding (March 2016)

DOWNLOAD PDF

Comments to ICER on Review of Diabetes Prevention Programs (March 2016)

DOWNLOAD PDF

Comments to Senate Finance Committee Chronic Care Working Group (January 2016)

DOWNLOAD PDF

Comments to Department of Health & Human Services (HHS) on 2017 Payment Notice (December 2015)

DOWNLOAD PDF

Letter to Speaker Ryan (December 2015)

DOWNLOAD PDF

Comments to Healthy People 2020 on Proposed Diabetes Screening Objective (November 2015)

DOWNLOAD PDF

Letter of Support for the Gestational Diabetes Act (October 2015)

DOWNLOAD PDF

Letter Reaffirming Support for the Access to Quality Diabetes Education Act (September 2015)

DOWNLOAD PDF

Letter to United States Preventive Services Task Force on screening in youth (July 2015)

DOWNLOAD PDF

Comments to Senate Finance Committee Chronic Care Working Group (June 2015)

DOWNLOAD PDF

Letter to Committee & Caucus Leaders Requesting Diabetes Hearing (June 2015)

DOWNLOAD PDF

Letter to Agency for Healthcare Research and Quality on diabetes screening guideline (May 2015)

DOWNLOAD PDF

Letter to Center for Consumer Information and Insurance Oversight on out-of-pocket cost estimates for Consumers (April 2015)

DOWNLOAD PDF

Letter to Surgeon General Vivek Murthy on Confirmation (March 2015)

DOWNLOAD PDF